United States Intoxicating Hemp-Derived Cannabinoids (IHDC) Regulatory Report 2022 – ResearchAndMarkets.com

- Advertisement -

DUBLIN–(BUSINESS WIRE)–The “US Regulatory Trends On Intoxicating Hemp-Derived Cannabinoids” report has been added to ResearchAndMarkets.com’s offering.

This report details and analyses recent developments in the regulation of IHDCs in the US.

- Advertisement -

Intoxicating hemp-derived cannabinoids (IHDC) – such as delta-8 THC, delta-10 THC, and hexahydrocannabinol (HHC) – have been major disruptors in the CBD and legal cannabis sectors in the US for some time now.

A trend has recently emerged where states have decided to regulate IHDC sales instead of banning them, thereby acknowledging their legal status.

Key Topics Covered:

- Advertisement -

1 Executive Summary

2 Introduction

3 Federal Developments

- Advertisement -

4 Summary Of IHDC Legislative Changes By State

READ MORE:  Global CBD Ingredients Market Report 2022: Supply Chain, Regulatory Environment, Competitive Environment, Regional Dynamics, Growth Opportunities - ResearchAndMarkets.com

5 States Regulating IHDCS Rather Than Banning

6 States Struggling To Regulate IHDCS

7 Another State Ban

8 Restrictive Recreational Cannabis States

9 The Future Of IHDCS In The US

For more information about this report visit https://www.researchandmarkets.com/r/kcsi9t

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

- Advertisement -

Latest News

Related articles